Kelly A. Kramer, Director at GILEAD SCIENCES, INC. (GILD), sold 11,222 shares at $127.11 ($1.4M) on 2025-11-26, disclosed to the SEC on 2025-12-01.
Scheduled sale ($1.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $127.11 | 2,806 | $357K | 25.0% |
| 2 | $127.11 | 2,806 | $357K | 25.0% |
| 3 | $127.10 | 2,805 | $357K | 25.0% |
| 4 | $127.10 | 2,805 | $357K | 25.0% |
| Total | $127.11 avg | 11,222 | $1.4M | 100% |
| Filing → |
| CSCO | SELL | 2020-02-28 | $4.6M | — | Filing → |
| CSCO | SELL | 2019-11-27 | $3.2M | — | Filing → |
| CSCO | SELL | 2019-08-30 | $3.3M | — | Filing → |